Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus–mechanisms …
Cardiovascular disease remains the principal cause of death and disability among patients
with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying …
with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying …
Early-life adversity and physical and emotional health across the lifespan: A neuroimmune network hypothesis
R Nusslock, GE Miller - Biological psychiatry, 2016 - Elsevier
Children who experience chronic stressors are vulnerable to emotional and physical health
problems across the lifespan. This phenomenon raises questions for scientists and …
problems across the lifespan. This phenomenon raises questions for scientists and …
Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update
As we know, inflammatory and oxidative stresses have a role in the pathogenesis of
cardiovascular disease. This knowledge has triggered many investigations targeted to …
cardiovascular disease. This knowledge has triggered many investigations targeted to …
Oral inflammation and infection, and chronic medical diseases: implications for the elderly
FA Scannapieco, A Cantos - Periodontology 2000, 2016 - Wiley Online Library
Oral diseases, such as caries and periodontitis, not only have local effects on the dentition
and on tooth‐supporting tissues but also may impact a number of systemic conditions …
and on tooth‐supporting tissues but also may impact a number of systemic conditions …
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial …
O Kleveland, G Kunszt, M Bratlie, T Ueland… - European heart …, 2016 - academic.oup.com
Abstract Aims Interleukin-6 (IL-6) contributes to atherosclerotic plaque destabilization and is
involved in myocardial injury during ischaemia–reperfusion. Interleukin-6 is therefore a …
involved in myocardial injury during ischaemia–reperfusion. Interleukin-6 is therefore a …
[HTML][HTML] Physical activity in primary and secondary prevention of cardiovascular disease: Overview updated
Although the observed progress in the cardiovascular disease treatment, the incidence of
new and recurrent coronary artery disease remains elevated and constitutes the leading …
new and recurrent coronary artery disease remains elevated and constitutes the leading …
[HTML][HTML] A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in …
J Allaire, P Couture, M Leclerc, A Charest… - The American journal of …, 2016 - Elsevier
Background: To date, most studies on the anti-inflammatory effects of eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) in humans have used a mixture of the 2 fatty acids …
(EPA) and docosahexaenoic acid (DHA) in humans have used a mixture of the 2 fatty acids …
[HTML][HTML] Comprehensive review of the impact of dairy foods and dairy fat on cardiometabolic risk
JP Drouin-Chartier, JA Côté, MÈ Labonté… - Advances in …, 2016 - Elsevier
Because regular-fat dairy products are a major source of cholesterol-raising saturated fatty
acids (SFAs), current US and Canadian dietary guidelines for cardiovascular health …
acids (SFAs), current US and Canadian dietary guidelines for cardiovascular health …
[HTML][HTML] Protective effect of irisin on atherosclerosis via suppressing oxidized low density lipoprotein induced vascular inflammation and endothelial dysfunction
Y Zhang, Q Mu, Z Zhou, H Song, Y Zhang, F Wu… - PloS one, 2016 - journals.plos.org
Irisin, a newly discovered myokine, is considered as a promising candidate for the treatment
of metabolic disturbances and cardiovascular diseases. In the present study, we used two …
of metabolic disturbances and cardiovascular diseases. In the present study, we used two …
Oxidative theory of atherosclerosis and antioxidants
R Salvayre, A Negre-Salvayre, C Camaré - Biochimie, 2016 - Elsevier
Atherosclerosis is a multifactorial process that begins early in infancy and affects all the
humans. Early steps of atherogenesis and the evolution towards complex atherosclerotic …
humans. Early steps of atherogenesis and the evolution towards complex atherosclerotic …